Triggered activity and arrhythmogenesis: A clinical update

ACC Current Journal Review

Volumn 6, Issue 4, 1997, Pages 16-19

  Shen, Win Kuang ^a   Terzic, Andre ^a   Stanton, Marshall S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACECAINIDE; ADENOSINE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CATECHOLAMINE; DISOPYRAMIDE; DOFETILIDE; ELECTROLYTE; IBUTILIDE FUMARATE; LIDOCAINE; MAGNESIUM; MEXILETINE; NORADRENALIN; PHENOTHIAZINE DERIVATIVE; POTASSIUM; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT; QUINIDINE; SODIUM; SOTALOL; TERFENADINE;

ACTION POTENTIAL; ARRHYTHMOGENESIS; BRADYCARDIA; ELECTROCARDIOGRAPHY; EXERCISE; GENE LOCATION; GENE MUTATION; GENETIC LINKAGE; HEART ARRHYTHMIA; HEART DEPOLARIZATION; HEART MUSCLE CELL; HEART PACING; HEART REPOLARIZATION; HUMAN; ION CURRENT; LONG QT SYNDROME; REVIEW; SODIUM CALCIUM EXCHANGE; TORSADE DES POINTES;

EID: 0030824908     PISSN: 10621458     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1062-1458(97)00045-7     Document Type: Review

References (15)

1. Wit AL, Rosen MR. Afterdepolarizations and triggered activity: distinction from automaticity as an arrhythmogenic mechanism. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. Heart and cardiovascular system: Scientific foundations, vol. 2, 2nd ed. New York: Raven Press, 1991:2113-63.
2. Antzelevitch C, Sicouri S. Clinical relevance of cardiac arrhythmias generated by afterdepolarizations. Role of M cells in the generation of U waves, triggered activity and torsade de points. J Am Coll Cardiol 1994;23: 259-77.
3. Brachmann J, Scherlag BJ, Rosenshtraukh LV, Lazzara R. Bradycardia-dependent triggered activity: relevance to drug-induced multiform ventricular tachycardia. Circulation 1983;68:846-56.
4. el-Sherif N, Zeiler RH, Craelius W, Gough WB, Henkin R. QTU prolongation and polymorphic ventricular tachyarrhythmias due to bradycardia-dependent early afterdepolarizations. Afterdepolarizations and ventricular arrhythmias. Circ Res 1988;63:286-305.
5. Kr. Implications for torsade de pointes and reverse use-dependence. Circulation 1996;93:407-11.
6. Ks contributes to the longer action potential of the M cell. Circ Res 1995;76:351-65.
7. Roden DM, Lazzara R, Rosen M, Schwartz PJ, Towbin J, Vincent GM. Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. Circulation 1996;94:1996-2012.
8. Tanaka T, Nagai R, Tomoike H, et al. Four novel KVLQT1 and four novel HERG mutations in familial long-QT syndrome. Circulation 1997; 95:565-7.
9. Ks cardiac potassium current. Nature 1996;384:78-80.
10. Ks potassium channel. Nature 1996; 384:80-3.
11. Splawski I, Timothy KW, Vincent GM, et al. Molecular basis of the long-QT syndrome associated with deafness. N Engl J Med 1996;336: 1562-7.
12. Moss AJ, Zareba W, Benhorin J, et al. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation 1995;92:2929-34.
13. Schwartz PJ, Priori SG, Locati EH, et al. Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation 1995;92:3381-6.
14. Comptom SJ, Lux RL, Ramsey MR, et al. Genetically defined therapy of inherited long-QT syndrome. Correction of abnormal repolarization by potassium. Circulation 1996;94:1018-22.
15. Shen WK, Kurachi Y. Mechanisms of adenosine-mediated actions on cellular and clinical cardiac electrophysiology. Mayo Clin Proc 1995;70: 274-91.